![]() Zenith Epigenetics Zenith Epigenetics is a biotechnology company developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders. | ||
Founding Date | Founding Date 2007 | Founding Date 2013 |
Type | Type Private | Type Subsidiary |
Tags | ||
Locations | Locations Tres Cantos, ES HQ | Locations San Francisco, US HQ Calgary, CA |
Employees | Employees 28 | Employees 118% decrease |
Funding | ||
Total funding raised | Total funding raised $ 9.4m | Total funding raised $ 16.6m |

Zenith Epigenetics is a biotechnology company developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders.
View company